Bayer CropScience Ltd (BAYERCROP) Q1 FY27 Results Analysis: EBITDA Margin Compresses 165 bps, PAT Margin Holds Up

Bayer CropScience Ltd's Q1 FY27 numbers came in soft, with revenue of Rs. 1,835.00 Cr (-4.16% YoY) and PAT growth of +15.39% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

Revenue declined 4.2% YoY and normalized EBITDA margin compressed 165 bps, driven by monsoon deficit impacting volumes. The balance sheet remains net cash with zero borrowings, and normalized PAT margin held flat, but underlying business faces demand weakness and margin pressure.

Key Investment Insights

Key Positives

• Reported PAT increased 15.4% YoY to Rs.321.6 Cr, though boosted by a one-time gain of Rs.63.9 Cr.
• Normalized PAT margin held broadly flat at 14.74% (vs 14.56% a year ago), indicating underlying cost discipline.
• Balance sheet remains net cash with zero borrowings (Rs.1,414.6 Cr net cash at FY26 year-end).
• Board recommended a final dividend of Rs.60 per share for FY26, reflecting strong cash position.

Risk Factors

• Revenue declined 4.2% YoY in Q1, a reversal from the prior year's strong growth, with monsoon deficit impacting volumes.
• Normalized EBITDA margin contracted 165 bps YoY to 16.55%, indicating underlying margin pressure.
• Normalized PAT declined 2.9% YoY to Rs.270.5 Cr after adjusting for one-time gains.
• Monsoon deficit and compressed spray window impacted crop protection volumes, with risk extending into the main Kharif season.